Logo 833 (Metoprolol succinate extended-release 200 mg)
Generic Name: metoprolol
Pill imprint Logo 833 has been identified as Metoprolol succinate extended-release 200 mg.
Metoprolol Succinate ER is used in the treatment of high blood pressure; supraventricular tachycardia; mitral valve prolapse; angina; heart failure (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol Succinate ER 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Logo 833
- 200 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
hypromellose 2910 (5 mPa.s)
polyethylene glycol 8000
polyethylene glycol 400
methacrylic acid - methyl methacrylate copolymer (1:2)
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|60429-0142||Golden State Medical Supply (repackager)|
More about Metoprolol Succinate ER (metoprolol)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 34 Reviews – Add your own review/rating
- Drug class: cardioselective beta blockers
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.